ResearcherWashington University in St. LouisNo recent work listed

Vincenza Cifarelli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9940-4106; OpenAlex author ID A5013123509. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper

Papers 1

Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms. Co-author DOI 10.2337/db14-1132 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laura M. Lashinger · 1 shared paper, 2015 · strength 0.05
- Paper Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechan… DOI 10.2337/db14-1132 ↗
Michaël Pollak · 1 shared paper, 2015 · strength 0.05
- Paper Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechan… DOI 10.2337/db14-1132 ↗
Stephen D Hursting · 1 shared paper, 2015 · strength 0.05
- Paper Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechan… DOI 10.2337/db14-1132 ↗
Rudolf Kaaks · 1 shared paper, 2015 · strength 0.05
- Paper Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechan… DOI 10.2337/db14-1132 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.